The pathogenetic mechanisms may include endothelial dysfunction, increased consumption of platelets and the decreased production of platelets, von Willebrand factor elevation, Toll-like receptor activation, and tissue-factor pathway activation12. The gene discussed is F3; the disease is endothelial dysfunction.